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Abstract
Introduction Inhalation injury in combination with a severe
thermal injury increases mortality. Alterations in inflammatory
mediators, such as cytokines, contribute to the incidence of
multi-organ failure and mortality. The aim of the present study
was to determine the effect of inhalation injury on cytokine
expression in severely burned children.
Methods Thirty severely burned pediatric patients with
inhalation injury and 42 severely burned children without
inhalation injury were enrolled in the study. Inhalation injury was
diagnosed by bronchoscopy during the first operation. Blood
was collected within 24 hours of admission and again at five to
seven days following admission. Cytokine expression was
profiled using multi-plex antibody-coated beads. Significance
was accepted at a p value of less than 0.05.
Results The mean percentages of total body surface area
burned were 67% ± 4% (56% ± 6%, third-degree burns) in the
inhalation injury group and 60% ± 3% (45% ± 3%, third-degree
burns) in the non-inhalation injury group (p value not significant
[NS]). Mean age was 9 ± 1 years in the inhalation injury group
and 8 ± 1 years in the non-inhalation injury group (p value NS).
Time from burn to admission in the inhalation injury group was 2
± 1 days compared to 3 ± 1 days in the non-inhalation injury
group (p value NS). Mortalities were 40% in the inhalation injury
group and 12% in the non-inhalation injury group (p < 0.05). At
the time of admission, serum interleukin (IL)-7 was significantly
increased in the non-inhalation injury group, whereas IL-12p70
was significantly increased in the inhalation injury group
compared to the non-inhalation injury group (p < 0.05). There
were no other significant differences between groups. Five to
seven days following admission, all cytokines decreased with no
differences between the inhalation injury and non-inhalation
injury cohorts.
Conclusion In the present study, we show that an inhalation
injury causes alterations in IL-7 and IL-12p70. There were no
increased levels of pro-inflammatory cytokines, indicating that an
inhalation injury in addition to a burn injury does not augment the
systemic inflammatory response early after burn.
Introduction
During the past 20 years, mortality from major burns has
decreased due to improved intensive care unit care, improve-
ments in wound management, better control of sepsis, and
control of hemodynamic disorders [1,2]. Of the injuries now
associated with burns, the single most important contributor to
mortality is inhalation injury. Twenty to thirty percent of all major
burns are associated with a concomitant inhalation injury and
a mortality of 25% to 50% when patients required ventilator
support for more than one week following injury [2].
Lung injury from smoke inhalation is associated with tracheo-
bronchial hyperemic sloughing of ciliated epithelium, formation
of copious tracheal exudates, and pulmonary capillary perme-
ability changes that result in a pulmonary edema [3]. Further
studies show a progressive increase in lung permeability soon
after thermal injury [4]. The inhalation of toxic smoke causes
the release of thromboxane and other mediators, which
increases pulmonary artery pressure and causes secondary
damage to the respiratory epithelium and release of chemotac-
tic factors [3]. Neutrophils subsequently undergo diapedeses
from the pulmonary microvasculature and release enzymes
such as elastase and free oxygen radicals, disrupting endothe-
lial junctions and the epithelial integrity, thus permitting an exu-
date of protein-rich plasma to enter the lung [3]. A
DC = dendritic cell; GM-CSF = granulocyte-macrophage colony-stimulating factor; IFN-γ = interferon-gamma; IL = interleukin; MIP-1β = macrophage 
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concomitant reduction in the pulmonary immune function may
lead to bacteria growth and pneumonia [5].
The pathophysiology of smoke inhalation injury has been well
studied; however, the molecular and cellular mechanisms are
still not entirely known. We hypothesized that the systemic
inflammatory response plays an important role in the clinical
aftermath of an inhalation injury. The systemic inflammatory
response to burn encompasses the release of large quantities
of cytokines such as interleukin (IL)-1β, IL-6, IL-8, or tumor
necrosis factor (TNF) [6-10]. Anti-inflammatory cytokines such
as IL-2, IL-4, or IL-10 are released concurrently in an attempt
to counter-regulate the effects of pro-inflammatory cytokines
[10]. Elevation of pro- and anti-inflammatory cytokines alters
immune function and protein metabolism, and these altera-
tions can lead to compromise of the structure and function of
multiple organ systems [6,11-14]. Hypermetabolism also
leads to futile protein use, resulting in induction of a dynamic
hypercatabolic state [15-18]. These findings delineate the
importance of cytokines as pro-inflammatory mediators. The
aim of the present study was to determine whether an inhala-
tion injury further augments the inflammatory response after a
severe burn injury, contributing to increased mortality via the
altered inflammatory response.
Materials and methods
Patients
Thirty severely burned children suffering from inhalation injury
and 42 severely burned children without inhalation injury were
enrolled in this prospective study (Figure 1). Inclusion criteria
were age of 16 years or younger, admission within seven days
after injury to the Shriners Hospitals for Children-Galveston
(Galveston, TX, USA), and burns covering more than 40% of
total body surface area (TBSA) with a third-degree component
of more than 34% requiring at least one surgical intervention
for escharotomy and skin grafting. Patients were excluded if
there was any sign of infection or sepsis or concomitant major
injuries or complications at admission.
After admission, patients were treated according to the stand-
ard of burn care at our institute, including early excision and
grafting of the burn wound and fluid and caloric resuscitation
according to the Galveston formulas [11]. Patients were fed
enterally due to our findings that total parenteral nutrition is
associated with higher mortality [19].
Diagnosis of inhalation injury was made by bronchoscopy dur-
ing the first operation, which usually occurs within 24 hours
after admission. An experienced anesthesiologist and/or respi-
ratory therapist performed the bronchoscopy and made the
diagnosis of inhalation injury based on the following: (a) Clini-
cal criteria were history of exposure to smoke in a closed
space (for example, patients who were stuporous or uncon-
scious) and presence of facial burns, singed nasal vibrissae,
bronchorrhea, sooty sputum, or auscultatory findings such as
wheezing or rales. (b) Laboratory criteria were hypoxemia and/
or elevated levels of carbon monoxide. (c) Bronchoscopy cri-
teria were airway edema, inflammation, mucosal necrosis,
presence of soot and charring in the airway, tissue sloughing,
or carbonaceous material in the airway.
The concentrations of serum cytokines from 15 unburned, nor-
mal pediatric patients are included for comparison to the
patients with inhalation injury and those without inhalation
injury (Figures 2, 3, 4, 5). These data were previously pub-
lished [10].
Serum cytokines
Blood was collected at the time of admission and again five to
seven days after admission. Blood was collected in serum-
separator collection tubes. The tubes were centrifuged for 10
minutes at 1,320 rpm, and the serum was removed and stored
at -70°C until assayed. Expression of 17 inflammatory media-
tors was measured using the Bio-Plex Human Cytokine 17-
Plex panel with the Bio-Plex Suspension Array System (Bio-
Rad Laboratories, Inc., Hercules, CA, USA). The following
cytokines are detected simultaneously with this multi-plexed
bead panel: IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-
12p70, IL-13, IL-17, granulocyte colony-stimulating factor (G-
CSF), granulocyte-macrophage colony-stimulating factor
(GM-CSF), interferon-gamma (IFN-γ), monocyte chemoat-
tractant protein-1, macrophage inflammatory protein-1-beta
(MIP-1β), and TNF. The assay was performed according to the
manufacturer's instructions. Briefly, serum samples were
thawed, centrifuged at 4,500 rpm for 3 minutes at 4°C, and
incubated with microbeads labeled with antibodies specific to
one of the aforementioned cytokines for 30 minutes. Following
a wash step, the beads were incubated with the detection anti-
body cocktail, each bead specific to a single cytokine. After
Figure 1
An outline of the study An outline of the study. To participate in the study, the patient had to be 
admitted to our institute within seven days after the burn injury. Patients 
were usually taken to the operating room (OR) within 48 hours after 
admission. Following evaluation of clinical signs and bronchoscopy 
findings, patients were then divided into control patients and those with 
inhalation injury. Blood was drawn at admission and three to five days 
after the first surgery.Available online http://ccforum.com/content/11/1/R22
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another wash step, the beads were incubated with
streptavidin-phycoerythrin for 10 minutes and washed and
then the concentrations of each cytokine were determined
using the array reader (Figures 2, 3, 4).
Ethics and statistics
The study was reviewed and approved by the Institutional
Review Board of the University of Texas Medical Branch
(Galveston, TX, USA). Prior to the study, each subject, parent,
or child's legal guardian signed a written informed consent
form. Two-tailed paired and unpaired Student t  tests were
used to compare differences in cytokine expressed. Data are
expressed as percentages or mean ± standard error of the
mean, where appropriate. Significance was accepted at a p
value of less than 0.05.
Results
Patient demographics are shown in Table 1. Children in the
non-inhalation injury group showed similar age, gender, per-
centage of TBSA burned, percentage of third-degree burn,
time from burn to admission, type of burn, and ethnicity com-
pared to patients in the inhalation injury group. There was also
no significant difference in length of hospital stay between the
two groups (Table 1). We found that patients suffering from
inhalation injury had a significantly higher mortality (43%; 13 of
30 patients) compared to burn patients without inhalation
injury (12%; 5 of 42 patients) (p < 0.05).
All measured cytokine concentrations were significantly
increased at the time of admission both in burned patients with
inhalation injury and in those without inhalation injury com-
pared to levels of non-burned, normal pediatric patients. By
comparing patients suffering from a burn plus inhalation injury
with patients suffering from a burn without inhalation injury, we
found that expressions of only two cytokines were significantly
different in the serum. Serum IL-7 was significantly higher in
the non-inhalation injury group compared to the inhalation
injury group (p < 0.05) (Figure 2a). Serum IL-12p70 was sig-
nificantly lower in the non-inhalation injury group compared to
patients with inhalation injury (p < 0.05) (Figure 2b). No other
cytokines were significantly different between the two groups.
We found that many cytokines significantly decreased from
admission to five to seven days after admission in both groups
(Figure 3a–i). These cytokines include IL-4, IL-6, IL-10, GM-
CSF, IFN-γ, TNF, IL-1β, G-CSF, and MIP-1β (p < 0.05). No
significant differences between the groups or significant
changes within the groups were found between admission
and five to seven days after admission for serum IL-2, IL-8, IL-
5, IL-13, and IL-17 (Figure 4). Cytokine profiles for the inhala-
tion injured and non-inhalation injured patients were generated
at the time of admission as well as five to seven days after
admission and compared to profiles from normal patients (Fig-
ure 5). The heatmap shows that the cytokine response is not
back to normal levels within this short post burn time period.
Discussion
Of the injuries associated with burns, the single most impor-
tant contributor to mortality is inhalation injury. Smoke inhala-
tion-induced lung injury increases sloughing of ciliated
epithelium, tracheal exudate production, and pulmonary capil-
lary permeability [3]. Because lung permeability is increased
soon after burn [4], resulting in accumulation of plasma in the
lung, we hypothesized that an inhalation injury augments the
inflammatory response and increases the systemic cytokine
expression. However, we found that an inhalation injury does
not augment the systemic inflammatory response but instead
Figure 2
Two cytokines were significantly different between patients with no  inhalation injury and those with an inhalation injury, namely interleukin  (IL)-7 and IL-12p70 Two cytokines were significantly different between patients with no 
inhalation injury and those with an inhalation injury, namely interleukin 
(IL)-7 and IL-12p70. (a) IL-7 was significantly increased in the group 
with no inhalation injury compared to the inhalation injury group. Normal 
IL-7: 3.8 ± 0.63 pg/ml. (b) IL-12p70 was significantly decreased in the 
group with no inhalation injury compared to the inhalation injury group. 
Normal IL-12 p70: 0 ± 0 pg/ml. *Significant difference between inhala-
tion injury group and group with no inhalation injury (p < 0.05). Data are 
presented as mean ± standard error of the mean. PAD, post-admission 
day.Critical Care    Vol 11 No 1    Finnerty et al.
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Figure 3
Cytokines presented demonstrated a significant decrease from admission to post-admission day (PAD) five to seven in the group with inhalation  injury and the group with no inhalation injury Cytokines presented demonstrated a significant decrease from admission to post-admission day (PAD) five to seven in the group with inhalation 
injury and the group with no inhalation injury. (a) Serum IL-4 (normal IL-4: 0 ± 0 pg/ml). (b) Serum IL-6 (normal IL-6: 8.7 ± 5 pg/ml). (c) Serum IL-10 
(normal IL-10: 1.4 ± 0.3 pg/ml). (d) Serum GM-CSF (normal GM-CSF: 0 ± 0 pg/ml). (e) Serum IFN-γ (normal IFN-γ : 1.4 ± 0.5 pg/ml). (f) Serum 
TNF (normal TNF: 0.7 ± 0.007 pg/ml). (g) Serum IL-1β (normal IL-1β : 0.91 ± 0.007 pg/ml). (h) Serum G-CSF (normal G-CSF: 1.2 ± 1.2 pg/ml). (i) 
Serum MIP-1β (normal MIP-1β : 37 ± 9 pg/ml). *Significant difference between admit and PAD 5–7 (p < 0.05). Data are presented as mean ± 
standard error of the mean. GM-CSF, granulocyte-macrophage colony-stimulating factor; G-CSF, granulocyte colony-stimulating factor; IFN-γ, inter-
feron-gamma; IL, interleukin; MIP-1β, macrophage inflammatory protein-1-beta; TNF, tumor necrosis factor.Available online http://ccforum.com/content/11/1/R22
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decreases IL-7 and increases IL-12p70 serum concentrations.
The reason why these particular cytokines are modulated in
response to inhalation injury is not known; however, we
hypothesize that cytokines are locally consumed in the lung,
thus lowering the overall systemic presence as measured in
the serum. We further showed that important pro-inflammatory
mediators known to be modulated in response to burn are not
significantly different in patients with inhalation injury. We
found that TNF, IL-6, and IL-8 all major inflammatory mediators
were not significantly different. Similar results were found by
Hales and colleagues [20] in an animal model, in which the
authors showed that TNF does not change with inhalation
injury. We have confirmed that TNF is not a major mediator
after inhalation injury.
Another animal study investigated the effect of inhalation injury
on alveolar macrophages [21]. The authors found that smoke-
exposed macrophages and inhalation of smoke suppressed
both alveolar macrophage adherence to plastic and phagocy-
tosis of opsonized bacteria. Basal superoxide production was
elevated whereas basal secretion of TNF was suppressed.
The authors concluded that the early responses of alveolar
macrophages to smoke inhalation lung injury consist of a func-
tional downregulation of phagocytosis.
In the present study of 72 patients, we found two discrete
cytokines that were significantly different in patients suffering
from inhalation injury versus patients with no inhalation injury,
IL-7 and IL-12p70. IL-7 was significantly higher in the patients
without inhalation injury. IL-7 is critical for regulating lymphoid
homeostasis and has been shown to be critical for the differ-
entiation of most T cells. Studies in IL-7 knockout mice
showed that IL-7 has anti-apoptotic effects on T cells via Bcl-
2 expression, indicating that IL-7 plays an important role in T-
Figure 4
Cytokines presented were expressed at similar concentrations in regardless of inhalation injury status or time post burn Cytokines presented were expressed at similar concentrations in regardless of inhalation injury status or time post burn. No significant differences or 
significant changes between admission and five to seven days after admission were found for (a) interleukin (IL)-2 (normal IL-2: 0 ± 0 pg/ml), (b) IL-
8 (normal IL-8: 8 ± 5 pg/ml), (c) IL-5 (normal IL-5: 0.7 ± 0.14 pg/ml), (d) IL-13 (normal IL-13: 0.9 ± 0.2 pg/ml), and (e) IL-17 (normal IL-17: 0 ± 0 
pg/ml). Data are presented as mean ± standard error of the mean. PAD, post-admission day.Critical Care    Vol 11 No 1    Finnerty et al.
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cell regulation and homeostasis [22]. IL-12p70 was signifi-
cantly increased in patients with inhalation injury. IL-12p70 has
IL-7-like effects on T-cell function and maturation but its role is
not as clearly understood [23]. In a recent study, it was shown
that mouse splenic CD8α+  and CDα-CD4-  dendritic cells
(DCs) had the ability to produce either IL-12p70 or IL-10
depending on the nature of the pathogen encountered. In con-
trast, CD4+ DCs seem incapable of producing IL-12p70 [24].
The exact role of IL-7 and IL-12p70 in the pathophysiologic
cascade following burn with smoke inhalation needs to be
determined.
We hypothesized that inhalation injury increases mortality by
increasing the systemic inflammatory response soon after
burn. The systemic inflammatory response after a severe burn
injury leads to hypermetabolism and to protein degradation.
Consequently, the structure and function of essential organs
such as the muscle, skin, heart, immune system, and liver are
compromised, contributing to multi-organ failure and mortality
[15,18]. It has been suggested that uncontrolled release of
pro-inflammatory mediators triggers and enhances protein
wasting and organ dysfunction [25,26]. Organ function break-
down can then lead to increased incidence of infection and
sepsis, ultimately leading to multi-organ failure and death. Our
results indicate that inhalation injury does not cause an aug-
mented inflammatory response. Thus, the mechanism by
which inhalation injury causes an increase in mortality is not
the systemic inflammatory response soon after burn. Based on
these results, we will determine the hypermetabolism and
energy expenditure in burned children with and without inhala-
tion injury in order to find the cause for the increased mortality
in burned children with inhalation injury.
A very important aspect that was outside the scope of this
study is the determination of cytokine levels in the lung.
Because we hypothesize that cytokines are locally increased
and that this causes the systemic cytokines to be decreased,
we have to perform a follow-up study in which we correlate
local (lung) cytokine concentrations in the bronchoalveolar lav-
age fluid to the levels of cytokines in the blood.
Conclusion
Inhalation injury is a major contributor to mortality in severely
burned patients. The molecular and cellular mechanisms by
which smoke inhalation causes this increase are not known.
Figure 5
Heat map comparing serum cytokine protein expression profiles of non- burn (Normal), burn (No II Admit or No II PAD 5–7), and burn plus inha- lation injury (II Admit or II PAD 5–7) groups Heat map comparing serum cytokine protein expression profiles of non-
burn (Normal), burn (No II Admit or No II PAD 5–7), and burn plus inha-
lation injury (II Admit or II PAD 5–7) groups. Values are log10 (average 
cytokine concentration, pg/ml) and blue indicates lower levels, yellow 
indicates highest levels, and black indicates levels in the middle. Gray 
squares indicate that no expression was detected. G-CSF, granulocyte 
colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-
stimulating factor; IFN, interferon; II Admit, inhalation injury group at 
admission; II PAD 5–7, inhalation injury group five to seven days after 
admission; IL, interleukin; MCP-1, monocyte chemoattractant protein-1; 
MIP-1β, macrophage inflammatory protein-1-beta; No II Admit, group 
with no inhalation injury, at admission; No II PAD 5–7, group with no 
inhalation injury, five to seven days after admission.
Table 1
Demographics for patients with no inhalation injury and inhalation injury
No inhalation injury Inhalation injury
Number 42 30
Age in years 8 ± 1 9 ± 1
Female/male 12/30 13/17
Percentage of TBSA burned 60 ± 3 67 ± 4
Third-degree burn percentage 45 ± 3 56 ± 6
Time to admission in days 3 ± 0.3 2 ± 0.3
Length of hospital stay in days 35 ± 6 37 ± 4
Mortality, number (percentage) 5 (12%) 13 (43%)a
aSignificant difference between control and inhalation injury groups (p < 0.05). TBSA, total body surface area.Available online http://ccforum.com/content/11/1/R22
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We hypothesized that inhalation injury augments the inflamma-
tory response and subsequently increases the hypermetabo-
lism and catabolism leading to multi-organ failure and death.
This was not the case, and our hypothesis was disproven. In
the present study, we showed that a severe burn with an inha-
lation injury causes decreased IL-7 and increased IL-12p70
cytokine levels at the time of admission to the hospital, but
these differences disappear following five to seven days after
admission. Because the altered cytokines play an important
role in the immune system and host defense, we suggest that
instead of an augmented systemic inflammatory response
soon after burn, immunocompromise and immunodysfunction
may be involved in the increased mortality in patients suffering
from burns plus inhalation injury.
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